tradingkey.logo
搜索

Bausch + Lomb Corp

BLCO
添加自选
16.553USD
-0.077-0.46%
交易中 美东报价延迟15分钟
5.86B总市值
亏损市盈率 TTM

Bausch + Lomb Corp

16.553
-0.077-0.46%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.46%

5天

+10.87%

1月

+5.77%

6月

-3.48%

今年开始到现在

-3.08%

1年

+33.50%

关键数据
16.620今开
16.620最高
207.16K成交量
亏损市盈率 TTM
14.84市盈率动
--股息TTM
0.06%换手率
16.630昨收
16.320最低
2.20M成交额
亏损市盈率静
0.91市净率
0.00%股息率 TTM
-1.55%ROA
18.91552周最高
0.63量比
-317.00M净利润
354.21M总股本
-0.6165每股收益TTM
0.58Beta
-3.44%ROE
11.22052周最低
1.80%振幅
56.59%毛利率
5.86B总市值
3.21回报/风险
1.95%风险率

TradingKey Bausch + Lomb Corp股票评分

单位: USD 更新时间: 2026-06-29

操作建议

Bausch + Lomb Corp当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名74/204位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价18.09。中期看,股价处于平稳状态。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Bausch + Lomb Corp评分

相关信息

行业排名
74 / 204
全市场排名
179 / 4570
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

Bausch + Lomb Corp亮点

亮点风险
Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
业绩高增长
公司营业收入稳步增长,连续3年增长23.03%
利润高增长
公司净利润处于行业前列,最新年度总收入5.10B美元
估值低估
公司最新PE估值-26.97,处于3年历史低位
机构减仓
最新机构持股40.30M股,环比减少38.29%
拉里·罗宾斯持仓
明星投资者拉里·罗宾斯持仓,最新持仓市值1.93M

分析师目标

根据 12 位分析师
持有
评级
18.091
目标均价
+10.85%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Bausch + Lomb Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Bausch + Lomb Corp简介

Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
公司代码BLCO
公司Bausch + Lomb Corp
CEOSaunders (Brenton L)
网址https://ir.bausch.com/

常见问题

Bausch + Lomb Corp(BLCO)的当前股价是多少?

Bausch + Lomb Corp(BLCO)的当前股价是 16.64。

Bausch + Lomb Corp的股票代码是什么?

Bausch + Lomb Corp的股票代码是BLCO。

Bausch + Lomb Corp股票的52周最高点是多少?

Bausch + Lomb Corp股票的52周最高点是18.91。

Bausch + Lomb Corp股票的52周最低点是多少?

Bausch + Lomb Corp股票的52周最低点是11.22。

Bausch + Lomb Corp的市值是多少?

Bausch + Lomb Corp的市值是5.94B。

现在Bausch + Lomb Corp(BLCO)的股票是买入、持有还是卖出?

根据分析师评级,Bausch + Lomb Corp(BLCO)的总体评级为signal_hold,目标价格为18.09。

Bausch + Lomb Corp(BLCO)股票的每股收益(EPS TTM)是多少

Bausch + Lomb Corp(BLCO)股票的每股收益(EPS TTM)是-1.02。
KeyAI